Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corp (NQ: TWST )

28.96 +1.00 (+3.58%)
Streaming Delayed Price Updated: 1:07 PM EST, Jan 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 202,724
Open 27.62
Bid (Size) 28.91 (2)
Ask (Size) 29.01 (4)
Prev. Close 27.96
Today's Range 27.41 - 29.00
52wk Range 21.78 - 66.15
Shares Outstanding 50,885,068
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important February 10 Deadline in Securities Class Action - TWST
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal
Twist Bioscience Begins Shipping Commercial Product from Synthetic DNA Manufacturing Factory of the Future
From Twist Bioscience Corporation
Via Business Wire

Performance

YTD
+21.63%
+21.63%
1 Month
+32.06%
+32.06%
3 Month
-13.47%
-13.47%
6 Month
-34.09%
-34.09%
1 Year
-44.58%
-44.58%

More News

Read More
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NewAge, Twist, Sunlight and Gaia and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via Globe NewsWire
5 Analysts Have This to Say About Twist Bioscience
Via Benzinga
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - TWST
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal
NASDAQ:TWST Shareholder Alert: Lawsuit Alleges Misleading Statements by Twist Bioscience
Via SBWire
Twist Bioscience to Report Fiscal 2023 First Quarter Financial Results on Friday, February 3, 2023
From Twist Bioscience Corporation
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NewAge, Twist, Sunlight and Gaia and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via Globe NewsWire
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - TWST
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Twist, Sunlight, Gaia, and Tattooed Chef and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via Globe NewsWire
CLASS ACTION ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Has Filed A Securities Fraud Class Action Lawsuit Against Twist Bioscience Corporation
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
ROSEN, A LEADING LAW FIRM, Encourages Twist Bioscience Corporation Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - TWST
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal
Twist Bioscience and CENTOGENE Launch Three Panels to Advance Rare Disease and Hereditary Cancer Research and Support Diagnostics
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience and Astellas Enter into Multitarget Antibody Discovery Research Collaboration
From Twist Bioscience Corporation
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NewAge, Twist, Sunlight and Gaia and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via Globe NewsWire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Silvergate, Iris, NewAge, and Twist and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via Globe NewsWire
Twist Bioscience to Present at the 41st Annual J.P. Morgan Health Care Conference
From Twist Bioscience Corporation
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
Via Benzinga
ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - TWST
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal
TWIST ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Twist Bioscience Corp and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via Globe NewsWire
Twist Bioscience Corporation (TWST) Class Action Notice: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Twist Bioscience Corporation
From Robbins LLP
Via Business Wire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Twist Bioscience Corporation Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - TWST
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal
TWIST ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Twist Bioscience Corp and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via Globe NewsWire
Bronstein, Gewirtz & Grossman, LLC Notifies Twist Bioscience Corporation (TWST) Investors of Class Action and to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.